Type / Class
Equity / American depositary shares, each representing one equity share
Shares outstanding
834,731,296
Number of holders
186
Total 13F shares, excl. options
24,973,479
Shares change
+520,792
Total reported value, excl. options
$1,381,318,862
Value change
+$28,786,696
Put/Call ratio
233%
Number of buys
98
Number of sells
-61
Price
$55.32

Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q2 2015

196 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q2 2015.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 186 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 24,973,479 shares of 834,731,296 outstanding shares and own 3% of the company stock.
Largest 10 shareholders include Fisher Asset Management, LLC (5,198,254 shares), COMMONWEALTH BANK OF AUSTRALIA (2,422,581 shares), AQR CAPITAL MANAGEMENT LLC (2,009,028 shares), VANGUARD GROUP INC (1,407,390 shares), BlackRock Group LTD (1,229,953 shares), SCHRODER INVESTMENT MANAGEMENT GROUP (888,833 shares), DIMENSIONAL FUND ADVISORS LP (585,417 shares), CAUSEWAY CAPITAL MANAGEMENT LLC (544,600 shares), ACADIAN ASSET MANAGEMENT LLC (510,142 shares), and PRUDENTIAL FINANCIAL INC (489,216 shares).
This table shows the top 186 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.